Results 221 to 230 of about 179,681 (354)

State-transition trajectories in out-of-hospital cardiac arrest: neurological outcomes beyond myocardial activity. [PDF]

open access: yesCrit Care
Kandori K   +6 more
europepmc   +1 more source

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Methods This multicenter international study includes patients with VEXAS from France, Israel, and Italy treated with ...
Tali Eviatar   +35 more
wiley   +1 more source

The rise of informed consent and retreat from dependence upon unclaimed bodies in anatomy: An overview and assessment

open access: yesAnatomical Sciences Education, EarlyView.
Abstract The development of anatomy has been marked by ethically questionable practices. This has been because the dissection of human bodies has always existed on the periphery of conventional society, necessitating a range of dubious ways of obtaining dead bodies for educational and research purposes.
David Gareth Jones
wiley   +1 more source

Timing and mode of death after pediatric in- and out-of-hospital cardiac arrest: a single center retrospective study. [PDF]

open access: yesResuscitation
McSherry ML   +9 more
europepmc   +1 more source

Nitrite elicits divergent NO-dependent signaling that associates with outcome in out of hospital cardiac arrest

open access: gold, 2020
Darío A. Vitturi   +9 more
openalex   +1 more source

Impact of COVID-19 Pandemic on Patients with ST-Segment-Elevation Myocardial Infarction Complicated by Out-of-Hospital Cardiac Arrest

open access: gold, 2022
Tomasz Tokarek   +6 more
openalex   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

When subarachnoid hemorrhage mimics acute coronary syndrome in out-of-hospital cardiac arrest: a diagnostic challenge. [PDF]

open access: yesInt J Emerg Med
Lahmouz Y   +10 more
europepmc   +1 more source

A real‐world data‐driven approach to optimizing enoxaparin dosing in burn patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Enoxaparin dosing in burn patients is challenging due to physiological changes affecting absorption, distribution and clearance. The objectives of this study are to develop a population pharmacokinetic (PK) model for enoxaparin in burn patients, evaluate target attainment with current equation‐based (EQ) dosing and propose an optimized dosing ...
Babajide Shenkoya   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy